ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 55 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $289,000 | +26.2% | 75,000 | 0.0% | 0.05% | +10.6% |
Q3 2015 | $229,000 | -28.0% | 75,000 | 0.0% | 0.05% | -24.2% |
Q2 2015 | $318,000 | +9.7% | 75,000 | 0.0% | 0.06% | +5.1% |
Q1 2015 | $290,000 | -42.6% | 75,000 | 0.0% | 0.06% | -44.9% |
Q4 2014 | $505,000 | +22.6% | 75,000 | 0.0% | 0.11% | +11.5% |
Q3 2014 | $412,000 | -46.4% | 75,000 | 0.0% | 0.10% | -45.1% |
Q2 2014 | $769,000 | -14.7% | 75,000 | 0.0% | 0.18% | -20.5% |
Q1 2014 | $901,000 | +6.2% | 75,000 | 0.0% | 0.22% | +4.3% |
Q4 2013 | $848,000 | +4.8% | 75,000 | 0.0% | 0.21% | -4.1% |
Q3 2013 | $809,000 | +16.4% | 75,000 | 0.0% | 0.22% | +14.6% |
Q2 2013 | $695,000 | – | 75,000 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |